Effect of cepharanthine hydrochloride on overcoming multidrug resistance and P-gp ATPase activity in mice model of hepatocellular carcinoma

Chinese Pharmacological Bulletin

Volumn 27, Issue 7, 2011, Pages 1002-1006

  Zang, Cai Hong ^a,b   Zhang, Yan ^a,c   Jiang, Jin Hua ^a,c   Wang, Ning ^a,c   Han, Li ^a,b   Ma, Fang ^a,c   Wang, Qing Duan ^a,c  

^a Henan Acadamy of Medical and Pharmaceutical Sciences ^*  (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c Henan Key Laboratory for Pharmacology of Liver Diseases   (China)

Author keywords

ATPase activity; Cepharanthine hydrochloride; H22 cell; H22 FAP cell; Hepatocellular carcinoma; Multidruge resistance; P glycoprotein

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOSINE TRIPHOSPHATE; CEPHARANTHINE; CEPHARANTHINE HYDROCHLORIDE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CANCER MODEL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SENSITIVITY; HYDROLYSIS; LIVER CELL CARCINOMA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; SURVIVAL TIME; TUMOR CELL;

EID: 80052497401     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2011.07.026     Document Type: Article

References (14)

1. But D Y, Lai C L, Yuen M F. Natural history of hepatitis-related hepatocellular carcinoma [J]. World J Gastroenterol, 2008,14 (11):1652-1656 (Pubitemid 351493370)
2. El-Serag H B, Davila J A, Petersen N J, McGlynn K A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update [J]. Ann Intern Med, 2003,139(10): 817-823
3. Shields A., Reddy K R. Hepatocellular carcinoma; current treatment strategies [J]. Curr Treat Options Gastroenterol, 2005,8(6): 457-466 (Pubitemid 43056142)
4. Ambudkar S V, Dey S., Hrycyna C A, et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J]. Annu Rev Pharmacol Toxicol, 1999,39:361-398 (Pubitemid 29222564)
5. Gottesman M M, Fojo T., Batas S E. Multidrug resistance in cancer: Role of ATP-dependent transporters [J]. Nat Rev Cancer, 2002,2 (1):48-58. (Pubitemid 37328807)
6. Kimura Y., Matsuo M., Takahashi K., et al. ATP hydrolysis-dependent multidrug efflux transporter: MDR1/P-glycoprotein [J]. Curr Drug Metab, 2004,5(1):1-10. (Pubitemid 38279405)
7. Dong X Z, Bi M G. Research progress on regulation of P-glycoprotein by reactive oxygen species [J]. Chin Pharmacol Bull, 2010, 26(10):1386-1390
8. Li X S, Lin Y., Hu Y H, et al. Research of antitumor effect of PH II-7 to K562/A02 cells [J]. Chin Pharmacol Bull, 2010, 26 (6):750-753
9. Tomita M., Fujitani K., Aoyagi Y. Synthesis of dl-cepharanthine [J]. Tetrahedron Lett, 1967,13:1201-1206
10. Kato T., Suzumura Y. Potentiation of antitumor acitivity of vincristine by biscoclaurine alkaloid cepharanthine [J]. Natl Cancer Inst, 1987,79(3):527-532 (Pubitemid 17126591)
11. Ji B S, He L. Effects of CJX1, an amlodipine derivative, on ATPase activity of human P-glycoprotein in resistant tumor cells [J]. Chin Pharmacol Bull, 2008,24(12):1603-1606
12. Wang X., Zhang Y., Wang N., et al. Establishment of Hca multidrug resistance mouse model [J]. J Zhengzhou Univ (Med Sci), 2010, 45(6):920-923
13. Asaumi J., Nishikawa K., Matsuoka H., et al. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice [J]. Anticancer Res, 1995,15(1): 67-70.
14. Wang T X, Yang X H. Reversal effect of isotetrandrine, all isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycopmtein-mediated Doxombicin-resistance in human breast cancer (MCF-7/DOX) cell s[J]. Acta Pharm Sin, 2008,43(5):461-466